abbvie glp-1 receptor agonist Frontiers “Weighing In” on GLP-1 Receptor

GLP-1 agonists are contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2

Pharmaceutical Online

Accessed June 22, 2007

Christian Wber: has received honoraria consultancy/speaking from Apomedica, Curelator, Eli Lilly, Grnenthal, Hermes, Lundbeck, Novartis, Pfizer, Ratiopharm/Teva, and Stada

This initial evaluation should also include kidney function tests, as these medications are generally avoided in patients with severe kidney dysfunction

Allulose, by contrast, doesn't cause blood sugar spikes, which keeps insulin levels at bay, and may therefore help improve insulin sensitivity